Extract to table
Pull the structured facts out of a document: parties, dates, amounts, obligations.
Extract to table / exclusivity-agreement.docx
exclusivity-agreement.docx
Parties
Hong Kong SA
Penterra Pharmaceuticals Corp
Harkness LLP
Firth LLP
Meridian Korea Inc
Meridian Bio Australia Pty Ltd
Alkerra Manufacturing Inc
Clarendon Bates LLP
Dates
August 4, 2023
July 18, 2023
October 3, 2023
November 2, 2023
Amounts
$120,000,000
$18,000,000
$32,000,000
$25,000,000
$45,000,000
Obligations
NOW, THEREFORE, in consideration of the mutual covenants and agreements set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows: ARTICLE 1 — DEFINITIONS As used in this Agreement, the following terms shall have the meanings set forth below
Capitalized terms used but not otherwise defined in this Agreement shall have the meanings ascribed to them in the Term Sheet
Without limiting the generality of the foregoing, for purposes of this Agreement, the Affiliates of Meridian shall include Meridian Pharma (Shanghai) Co
During the Exclusivity Period, Meridian shall not, and shall cause its Affiliates (including, without limitation, Meridian Pharma (Shanghai) Co
4 shall not be construed to limit or diminish in any way the scope of the exclusivity obligations set forth in Sections 2
The Exclusivity Period shall commence on the Effective Date (August 4, 2023) and shall expire at 11:59 p